• Sinéad Weldon, Paul McNally, Danny F McAuley, Irene K Oglesby, Christine L Wohlford-Lenane, Jennifer A Bartlett, Christopher J Scott, Noel G McElvaney, Catherine M Greene, Paul B McCray, and Clifford C Taggart.
• 1 Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, and.
• Am. J. Respir. Crit. Care Med. 2014 Jul 15; 190 (2): 165-74.

RationaleCathepsin S (CTSS) activity is increased in bronchoalveolar lavage (BAL) fluid from patients with cystic fibrosis (CF). This activity contributes to lung inflammation via degradation of antimicrobial proteins, such as lactoferrin and members of the β-defensin family.ObjectivesIn this study, we investigated the hypothesis that airway epithelial cells are a source of CTSS, and mechanisms underlying CTSS expression in the CF lung.MethodsProtease activity was determined using fluorogenic activity assays. Protein and mRNA expression were analyzed by ELISA, Western blotting, and reverse-transcriptase polymerase chain reaction.Measurements And Main ResultsIn contrast to neutrophil elastase, CTSS activity was detectable in 100% of CF BAL fluid samples from patients without Pseudomonas aeruginosa infection. In this study, we identified epithelial cells as a source of pulmonary CTSS activity with the demonstration that CF airway epithelial cells express and secrete significantly more CTSS than non-CF control cells in the absence of proinflammatory stimulation. Furthermore, levels of the transcription factor IRF-1 correlated with increased levels of its target gene CTSS. We discovered that miR-31, which is decreased in the CF airways, regulates IRF-1 in CF epithelial cells. Treating CF bronchial epithelial cells with a miR-31 mimic decreased IRF-1 protein levels with concomitant knockdown of CTSS expression and secretion.ConclusionsThe miR-31/IRF-1/CTSS pathway may play a functional role in the pathogenesis of CF lung disease and may open up new avenues for exploration in the search for an effective therapeutic target.

41 keywords...

hide…